Intensive voice treatment in Parkinson’s disease: Lee Silverman Voice Treatment

Advances in neuroscience have led to an expanded and improved understanding of neurobiological changes associated with rehabilitation and exercise in Parkinson’s disease (PD). This knowledge has led to a direct clinical impact of increased referral for early and continuous exercise programs for individuals with PD (physical, occupational, speech therapy and general exercise programs) and an increased research focus on the impact of such approaches in humans with PD. The purpose of this article is to examine the role of speech therapy in the landscape of exercise-based interventions for individuals with PD. We will specifically focus on the intensive voice treatment protocol, Lee Silverman Voice Treatment, as an example therapy. This article will briefly review the literature on the characteristics and features of speech and voice disorders in individuals with PD, and will discuss the impact of pharmacological and surgical treatment techniques on these disorders. This will be followed by a focus on behavioral speech treatment, specifically Lee Silverman Voice Treatment, including development of the treatment approach, documenting efficacy, discovery of unexpected outcomes and insights into the mechanism of speech disorders in PD gained from treatment-related changes. This research will be placed in the context of other previous and current speech treatment approaches in development for individuals with PD, and will highlight future directions for research.

[1]  Scott T. Grafton,et al.  The basal ganglia network mediates the planning of movement amplitude , 2004, The European journal of neuroscience.

[2]  R. Leanderson,et al.  Electromyographic studies of the function of the facial muscles in dysarthria. , 1969, Acta oto-laryngologica. Supplementum.

[3]  S. Skodda,et al.  Vowel articulation in Parkinson's disease. , 2011, Journal of voice : official journal of the Voice Foundation.

[4]  J. Abbs,et al.  Response properties of the perioral reflex in parkinson's disease , 1987, Experimental Neurology.

[5]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[6]  Raymond D. Kent,et al.  Task-Based Profile of Vocal Intensity Decline in Parkinson’s Disease , 2005, Folia Phoniatrica et Logopaedica.

[7]  R. Huebner,et al.  Videophone-delivered voice therapy: a comparative analysis of outcomes to traditional delivery for adults with Parkinson's disease. , 2008, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[8]  K. Yorkston,et al.  Behavioral management of respiratory/phonatory dysfunction from dysarthria , 2003 .

[9]  S. Countryman,et al.  Comparison of two forms of intensive speech treatment for Parkinson disease. , 1995, Journal of speech and hearing research.

[10]  C. Markham,et al.  Deficits in orofacial sensorimotor function in Parkinson's disease , 1986, Annals of neurology.

[11]  V. Hammen,et al.  Lip muscle activity related to speech rate and loudness. , 2000, Journal of speech, language, and hearing research : JSLHR.

[12]  P. Lachenbruch Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[13]  T. Pring,et al.  Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study. , 2009, International journal of language & communication disorders.

[14]  A. Graybiel The Basal Ganglia and Chunking of Action Repertoires , 1998, Neurobiology of Learning and Memory.

[15]  Karl J. Friston,et al.  Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions. , 2002, Brain : a journal of neurology.

[16]  A. Benabid,et al.  Effect of Bilateral Stimulation of the Subthalamic Nucleus on Parkinsonian Voice , 2001, Brain and Language.

[17]  A. Benabid,et al.  Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  B. Murdoch,et al.  Effect of oral levodopa treatment on articulatory function in Parkinson's disease: preliminary results. , 1998, Motor control.

[19]  N. Solomon,et al.  Speech breathing in Parkinson's disease. , 1993, Journal of speech and hearing research.

[20]  E. Lin,et al.  Glottographic Measures Before and After Levodopa Treatment in Parkinson's Disease , 1999, The Laryngoscope.

[21]  Robert M. Seyfarth,et al.  Male chacma baboons (Papio hamadryas ursinus) discriminate loud call contests between rivals of different relative ranks , 2004, Animal Cognition.

[22]  K. Verdolini,et al.  Interrelation of mandibular laryngeal functions. , 1999, Journal of voice : official journal of the Voice Foundation.

[23]  S. Leurgans,et al.  Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s disease , 2000, Neurology.

[24]  B. Meyerson,et al.  Lip muscle function in Parkinsonian Dysarthria. , 1972, Acta oto-laryngologica.

[25]  A. Aronson,et al.  Aphonia after closed head injury: aetiologic considerations. , 1985, The British journal of disorders of communication.

[26]  J. Summers,et al.  Abnormalities in the stride length‐cadence relation in parkinsonian gait , 1998, Movement disorders : official journal of the Movement Disorder Society.

[27]  L. Ramig,et al.  Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: A preliminary study , 2007, Behavioural Brain Research.

[28]  Julie M Liss,et al.  The effects of familiarization on intelligibility and lexical segmentation in hypokinetic and ataxic dysarthria. , 2002, The Journal of the Acoustical Society of America.

[29]  Jay J Bauer,et al.  Vocal responses to unanticipated perturbations in voice loudness feedback: an automatic mechanism for stabilizing voice amplitude. , 2006, The Journal of the Acoustical Society of America.

[30]  E S Luschei,et al.  Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging , 1998, Neurology.

[31]  G. Miller,et al.  Book Review: Forced Limb-Use and Recovery following Brain Injury , 2002 .

[32]  A. Albanese,et al.  Dopaminergic therapy and subthalamic stimulation in Parkinson’s disease: a review of 5-year reports , 2010, Journal of Neurology.

[33]  Andrew J. Lees,et al.  Speech therapy in Parkinson's disease , 2002 .

[34]  J. Gordon,et al.  The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease. , 2008, Archives of physical medicine and rehabilitation.

[35]  Peter T Fox,et al.  Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance–correlation analysis , 2009, Human brain mapping.

[36]  R Iansek,et al.  Regulation of parkinsonian speech volume: the effect of interlocuter distance , 1999, Journal of neurology, neurosurgery, and psychiatry.

[37]  R. Schulman,et al.  Articulatory dynamics of loud and normal speech. , 1989, The Journal of the Acoustical Society of America.

[38]  A. Benabid,et al.  Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism , 1999, Journal of neurology, neurosurgery, and psychiatry.

[39]  U. Jürgens,et al.  The anterior cingulate cortex and the phonatory control in monkey and man , 1983, Neuroscience & Biobehavioral Reviews.

[40]  Hermann Ackermann,et al.  Speech perception deficits in Parkinson's disease: underestimation of time intervals compromises identification of durational phonetic contrasts , 2002, Brain and Language.

[41]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[42]  John C Marshall,et al.  Micrographia in Parkinson’s disease: the effect of providing external cues , 1997, Journal of neurology, neurosurgery, and psychiatry.

[43]  Theresa A. Jones,et al.  Motor Enrichment and the Induction of Plasticity Before or After Brain Injury , 2003, Neurochemical Research.

[44]  C. Markham,et al.  Oral sensorimotor defects in patients with Parkinson's disease. , 1987, Advances in neurology.

[45]  M. Hallett,et al.  A mismatch between kinesthetic and visual perception in Parkinson's disease , 1997, Annals of neurology.

[46]  S. Tasko,et al.  Association of orofacial with laryngeal and respiratory motor output during speech , 2002, Experimental Brain Research.

[47]  R. Iansek,et al.  Speech impairment in a large sample of patients with Parkinson's disease. , 1998, Behavioural neurology.

[48]  Elina Tripoliti,et al.  Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation , 2008, Movement disorders : official journal of the Movement Disorder Society.

[49]  Robert Iansek,et al.  Volume perception in Parkinsonian speech , 2000, Movement disorders : official journal of the Movement Disorder Society.

[50]  Susan Duncan,et al.  Preliminary data on effects of behavioral and levodopa therapies on speech-accompanying gesture in parkinson²s disease , 2002, INTERSPEECH.

[51]  Jeri Logemann,et al.  Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study , 2002, INTERSPEECH.

[52]  Lorraine O. Ramig,et al.  Speech Loudness and Quality 12 Months after Intensive Voice Treatment (LSVT®) for Parkinson’s Disease: A Comparison with an Alternative Speech Treatment , 2002, Folia Phoniatrica et Logopaedica.

[53]  Stephen Wilson,et al.  Treating the speech disorder in Parkinson's disease online , 2006 .

[54]  L. Ramig,et al.  The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. , 2006, Seminars in speech and language.

[55]  P. Watson,et al.  The relationship of vocal loudness manipulation to prosodic F0 and durational variables in healthy adults. , 2006, Journal of speech, language, and hearing research : JSLHR.

[56]  M. Aminoff,et al.  Sensory perception in Parkinson disease. , 1997, Archives of neurology.

[57]  L. Ramig,et al.  Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. , 1995, Journal of voice : official journal of the Voice Foundation.

[58]  Scott T. Grafton,et al.  Basal ganglia network mediates the control of movement amplitude , 2003, Experimental Brain Research.

[59]  Serge Pinto,et al.  Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria , 2003, Brain and Language.

[60]  A. Benabid,et al.  Effect of Bilateral Deep-Brain Stimulation on Oral Control of Patients with Parkinsonism , 2000, European Neurology.

[61]  J. Summers,et al.  Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. , 1996, Brain : a journal of neurology.

[62]  Hermann Ackermann,et al.  The Temporal Control of Repetitive Articulatory Movements in Parkinson's Disease , 1997, Brain and Language.

[63]  S. Countryman,et al.  Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls , 2001, Movement disorders : official journal of the Movement Disorder Society.

[64]  J. Kleim,et al.  Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. , 2008, Journal of speech, language, and hearing research : JSLHR.

[65]  Jennifer L. Spielman,et al.  The Effects of Intensive Voice Treatment on Facial Expressiveness in Parkinson Disease: Preliminary Data , 2003, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[66]  G. Nappi,et al.  The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study. , 2009, Parkinsonism & related disorders.

[67]  L. Ramig,et al.  The Lee Silverman Voice Treatment® for voice, speech and other orofacial disorders in patients with Parkinson’s disease , 2006 .

[68]  Anthony E. Lang,et al.  Movement Disorders: A Comprehensive Survey , 1989 .

[69]  M. Borutta,et al.  A defect of kinesthesia in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[70]  L. Ramig,et al.  Current Perspectives on the Lee Silverman Voice Treatment (LSVT) for Individuals With Idiopathic Parkinson Disease , 2002 .

[71]  R Netsell,et al.  Vowel-related differences in laryngeal articulatory and phonatory function. , 1998, Journal of speech, language, and hearing research : JSLHR.

[72]  W Poewe,et al.  Repetitive speech phenomena in Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[73]  Lorraine O. Ramig,et al.  The Lee Silverman Voice Treatment: A Practical Guide to Treating the Voice and Speech Disorders in Parkinson’s Disease , 1995 .

[74]  M. Zigmond,et al.  Forced Limb-Use Effects on the Behavioral and Neurochemical Effects of 6-Hydroxydopamine , 2001, The Journal of Neuroscience.

[75]  M. Cosio,et al.  Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. , 1984, The New England journal of medicine.

[76]  Danny Rafferty,et al.  The effect of cueing therapy on single and dual‐task gait in a drug naïve population of people with Parkinson's disease in northern Tanzania , 2010, Movement disorders : official journal of the Movement Disorder Society.

[77]  S. Sapir,et al.  Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. , 2001, Journal of voice : official journal of the Voice Foundation.

[78]  M. McNeil Clinical Management of Sensorimotor Speech Disorders , 2008 .

[79]  W. Rausch,et al.  Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. , 2005, Pharmacological reports : PR.

[80]  L. Ramig,et al.  Speech and swallowing disorders in Parkinson disease , 2008, Current opinion in otolaryngology & head and neck surgery.

[81]  A Karni,et al.  Skill learning in mirror reading: how repetition determines acquisition. , 2003, Brain research. Cognitive brain research.

[82]  S. Robertson,et al.  Speech therapy in Parkinson's disease: a study of the efficacy ad long term effects of intensive treatment. , 1984, The British journal of disorders of communication.

[83]  F. W. Cody,et al.  Proprioceptive control of wrist movements in Parkinson's disease. Reduced muscle vibration-induced errors. , 1997, Brain : a journal of neurology.

[84]  A. Goberman,et al.  Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[85]  R. Iansek,et al.  Movement‐related potentials in Parkinson's disease: External cues and attentional strategies , 1999, Movement disorders : official journal of the Movement Disorder Society.

[86]  M. Greene,et al.  The voice and its disorders , 1957 .

[87]  C. Larson,et al.  Effect of duration of pitch-shifted feedback on vocal responses in patients with Parkinson's disease. , 2001, Journal of speech, language, and hearing research : JSLHR.

[88]  A. Benabid,et al.  Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech , 2005, Movement disorders : official journal of the Movement Disorder Society.

[89]  L. Ramig,et al.  Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease. , 1996, Journal of speech and hearing research.

[90]  R. Iansek,et al.  Speech volume regulation in Parkinson’s disease: effects of implicit cues and explicit instructions , 1999, Neuropsychologia.

[91]  T. Pring,et al.  Speech therapy and Parkinson's disease: a review and further data. , 1990, The British journal of disorders of communication.

[92]  Karin Wårdell,et al.  Patient-Specific Model-Based Investigation of Speech Intelligibility and Movement during Deep Brain Stimulation , 2010, Stereotactic and Functional Neurosurgery.

[93]  Barry E. Levin,et al.  Neurobiology of exercise , 2006, Obesity.

[94]  M. Caligiuri The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria , 1989, Brain and Language.

[95]  Michael J. Hammer Design of a New Somatosensory Stimulus Delivery Device for Measuring Laryngeal Mechanosensory Detection Thresholds in Humans , 2009, IEEE Transactions on Biomedical Engineering.

[96]  M. Gentil,et al.  The Effect of Levodopa on Vocal Function in Parkinson's Disease , 2001, Clinical neuropharmacology.

[97]  Stephen J Wilson,et al.  Home-based speech treatment for Parkinson's disease delivered remotely: a case report , 2010, Journal of telemedicine and telecare.

[98]  B. Murdoch,et al.  Changes in Maximum Capacity Tongue Function following the Lee Silverman Voice Treatment Program , 2000 .

[99]  S. Sapir,et al.  Orolaryngeal reflex responses to changes in affective state. , 1995, Journal of speech and hearing research.

[100]  S. Rehncrona,et al.  Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation , 2005, Movement disorders : official journal of the Movement Disorder Society.

[101]  R. West,et al.  Neurons of the anterior mesial cortex related to faciovocal activity in the awake monkey. , 1995, Journal of neurophysiology.

[102]  David R. Beukelman,et al.  Evidence for effectiveness of treatment of loudness, rate, or prosody in dysarthria: a systematic review , 2007 .

[103]  M. Schultz,et al.  A model for conducting clinical-outcome research: An adaptation of the standard protocol for use in aphasiology , 1998 .

[104]  V. Russell,et al.  Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. , 2009, Parkinsonism & related disorders.

[105]  G. Miller,et al.  Forced limb-use and recovery following brain injury. , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[106]  C. M. Allan Treatment of non fluent speech resulting from neurological disease--treatment of dysarthria. , 1970, The British journal of disorders of communication.

[107]  H. Hirose,et al.  Pathophysiology of motor speech disorders (dysarthria). , 1986, Folia phoniatrica.

[108]  H. Fankhauser,et al.  Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. , 1999, Journal of neurosurgery.

[109]  Edith Whetnall,et al.  Book Review: Principles of Bone X-ray Diagnosis , 1965 .

[110]  S. Countryman,et al.  Intensive speech treatment for patients with Parkinson's disease , 1996, Neurology.

[111]  Patrick Santens,et al.  The effects of levodopa on word intelligibility in Parkinson's disease. , 2005, Journal of communication disorders.

[112]  M T Sarno,et al.  Speech impairment in Parkinson's disease. , 1968, Archives of physical medicine and rehabilitation.

[113]  L. Ramig,et al.  Intentional changes in sound pressure level and rate: their impact on measures of respiration, phonation, and articulation. , 1998, Journal of speech, language, and hearing research : JSLHR.

[114]  K. Leenders,et al.  Parkinson's disease: The syndrome, the pathogenesis and pathophysiology , 2009, Cortex.

[115]  S. Skodda,et al.  Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease , 2010, Journal of Neural Transmission.

[116]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[117]  L. Ramig,et al.  The effect of lung volume on selected phonatory and articulatory variables. , 1998, Journal of speech, language, and hearing research : JSLHR.

[118]  M. Hirsch,et al.  Exercise and neuroplasticity in persons living with Parkinson's disease. , 2009, European journal of physical and rehabilitation medicine.

[119]  L. Ramig,et al.  Speech treatment for Parkinson's disease. , 2005, NeuroRehabilitation.

[120]  R Iansek,et al.  Motor instability in parkinsonian speech intensity. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[121]  Michael J. Hammer,et al.  Laryngeal somatosensory deficits in Parkinson’s disease: implications for speech respiratory and phonatory control , 2010, Experimental Brain Research.

[122]  N. Biary,et al.  A double‐blind trial of clonazepam in the treatment of parkinsonian dysarthria , 1988, Neurology.

[123]  E. Kokmen,et al.  The paramedian diencephalic syndrome: a dynamic phenomenon. , 1987, Stroke.

[124]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[125]  F. Caird,et al.  Speech therapy for Parkinson's disease. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[126]  G. Weismer,et al.  Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. , 1989, The Journal of the Acoustical Society of America.

[127]  S. Tasko,et al.  Association of orofacial muscle activity and movement during changes in speech rate and intensity. , 2003, Journal of speech, language, and hearing research : JSLHR.

[128]  G. Miller,et al.  Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease , 2003, Neuroscience.

[129]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[130]  U. Jürgens,et al.  The Effects of Deep-Reaching Lesions in the Cortical Face Area on Phonation a Combined Case Report and Experimental Monkey Study , 1982, Cortex.

[131]  J. Schneider,et al.  Basal ganglia and behavior : sensory aspects of motor functioning , 1987 .

[132]  Bastiaan R Bloem,et al.  Physical therapy in Parkinson's disease: Evolution and future challenges , 2009, Movement disorders : official journal of the Movement Disorder Society.

[133]  S. Countryman,et al.  Intensive voice treatment (LSVT®) for patients with Parkinson's disease: a 2 year follow up , 2001 .

[134]  N. Bohnen,et al.  Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia , 2006, Journal of Neurology.

[135]  Jennifer L. Spielman,et al.  Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech. , 2010, Journal of speech, language, and hearing research : JSLHR.

[136]  H. Ackermann,et al.  Articulatory deficits in parkinsonian dysarthria: an acoustic analysis. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[137]  S. Sapir,et al.  Supralaryngeal muscle activity during sustained vibrato in four sopranos: surface EMG findings. , 1993, Journal of voice : official journal of the Voice Foundation.

[138]  Synnöve Carlson,et al.  Shared means and meanings in vocal expression of man and macaque , 2003, Logopedics, phoniatrics, vocology.

[139]  M. Hallett,et al.  Pathophysiology of bradykinesia in Parkinson's disease. , 2001, Brain : a journal of neurology.

[140]  C. Coelho,et al.  Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states. , 2002, Journal of communication disorders.

[141]  L. Ramig,et al.  Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study. , 1995, Journal of speech and hearing research.

[142]  S. Sapir,et al.  Effect of geniohyoid, cricothyroid and sternothyroid muscle stimulation on voice fundamental frequency of electrically elicited phonation in rhesus macaque , 1981, The Laryngoscope.

[143]  Jennifer L. Spielman,et al.  Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. , 2007, Journal of speech, language, and hearing research : JSLHR.

[144]  George D. Allen,et al.  Segmental timing control in speech production , 1973 .

[145]  G. Akopian,et al.  Enhancing neuroplasticity in the basal ganglia: The role of exercise in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[146]  U. Jürgens,et al.  The role of the periaqueductal grey in limbic and neocortical vocal fold control , 1996, Neuroreport.

[147]  S. Sapir The intrinsic pitch of vowels: Theoretical, physiological, and clinical considerations , 1989 .

[148]  L. Ramig,et al.  The Parkinson larynx: tremor and videostroboscopic findings. , 1996, Journal of voice : official journal of the Voice Foundation.

[149]  K. Tjaden,et al.  Rate and loudness manipulations in dysarthria: acoustic and perceptual findings. , 2004, Journal of speech, language, and hearing research : JSLHR.

[150]  J. Gandour,et al.  Speech Timing at the Sentence Level in Thai After Unilateral Brain Damage , 1994, Brain and Language.

[151]  A Smith,et al.  Speech motor stability in IPD: effects of rate and loudness manipulations. , 2001, Journal of speech, language, and hearing research : JSLHR.

[152]  M. Horstink,et al.  Improvement of voicing in patients with Parkinson’s disease by speech therapy , 2003, Neurology.

[153]  K. Morgan,et al.  Dopaminergic Medication Effects on the Speech of Individuals with Parkinson's Disease , 2009 .

[154]  Shimon Sapir,et al.  Articulatory changes in muscle tension dysphonia: evidence of vowel space expansion following manual circumlaryngeal therapy. , 2009, Journal of communication disorders.